Related Experiment Videos
Pathogenic expression of homoplasmic mtDNA mutations needs a complex nuclear-mitochondrial interaction.
Valerio Carelli1, Carla Giordano, Giulia d'Amati
1Dipartimento di Scienze Neurologiche, Universita' di Bologna, Via Ugo Foscolo 7, 40123 Bologna, Italy. carelli@neuro.unibo.it
Trends in Genetics : TIG
|April 25, 2003
Summary
Mitochondrial DNA (mtDNA) mutations cause inherited disorders, but nuclear genes also influence disease severity. This suggests a two-locus model for these conditions.
Area of Science:
- Genetics
- Molecular Biology
- Human Pathology
Background:
- Mitochondrial DNA (mtDNA) mutations are linked to various human inherited disorders.
- These disorders often exhibit homoplasmic mutations, variable penetrance, and tissue-specific clinical manifestations.
- Examples include Leber's hereditary optic neuropathy and mitochondrial hypertrophic cardiomyopathy.
Purpose of the Study:
- To define a category of maternally inherited disorders caused by homoplasmic mtDNA mutations.
- To investigate the genetic basis of variable penetrance and tissue specificity in these disorders.
- To propose a two-locus genetic model involving mtDNA and nuclear factors.
Main Methods:
- Analysis of clinical and genetic data from patients with specific maternally inherited disorders.
- Review of evidence supporting the role of nuclear modifiers in mtDNA-related pathologies.
- Hypothesizing the nature and function of nuclear modifier genes.
Main Results:
- Identified a category of human disorders characterized by homoplasmic mtDNA pathogenic mutations.
- Established that mtDNA mutations are necessary but not sufficient for disease development.
- Evidence suggests a two-locus model involving a primary mtDNA mutation and a nuclear modifier gene.
Conclusions:
- Maternally inherited disorders with homoplasmic mtDNA mutations involve a two-locus genetic interaction.
- Nuclear modifier genes, potentially encoding tissue-specific proteins, influence disease expression.
- Understanding this interaction is crucial for diagnosing and potentially treating these mitochondrial disorders.